DEF: Castellum, Inc. Seeks Stockholder Approval for Director Elections, Incentive Plan Amendment, and Employee Stock Purchase Plan

Castellum, Inc. is soliciting proxies for its 2025 Annual Meeting of Stockholders, covering director elections, ratification of auditors, an amendment to the stock incentive plan, and adoption of an employee stock purchase plan.

Summary

• Castellum, Inc. has released its proxy statement for the 2025 Annual Meeting of Stockholders to be held on May 28, 2025.
• Stockholders will vote on the election of six director nominees, including Glen R. Ives, the current President and CEO, as a new director nominee.
• The company is seeking ratification of the appointment of RSM US LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• A key proposal involves amending the Castellum, Inc. Amended 2021 Stock Incentive Plan to increase the aggregate number of shares reserved for issuance to 9,000,000.
• Stockholders will also vote on the adoption of the Castellum, Inc. 2025 Employee Stock Purchase Plan, which reserves 3,000,000 shares for employee purchase.
• The Board of Directors recommends voting 'FOR' all proposals.

Sentiment

Score: 7

Explanation: The document is primarily informational and procedural, with a neutral to slightly positive tone. The proposals aim to incentivize employees and align their interests with stockholders, which is generally viewed favorably.

Positives

• The proposed amendment to the stock incentive plan aims to attract and retain key employees and directors.
• The Employee Stock Purchase Plan provides employees with an opportunity to acquire an equity interest in the company.
• The Board is committed to good corporate governance, including director independence and risk oversight.
• The company has a clawback policy in place to recover incentive compensation in the event of financial restatements.

Negatives

• Deferred Board and committee chair fees accrued to $515,221 at December 31, 2024.
• The issuance of additional shares under the incentive plan and employee stock purchase plan may dilute existing stockholders' ownership.
• One director, Jay O. Wright, was a director of Nutroganics, Inc. within two years of its bankruptcy.
• Another director, C. Thomas McMillen, was an independent director of RCS Capital Corporation when it filed for bankruptcy.

Risks

• Failure to obtain stockholder approval for the proposed amendments could limit the company's ability to attract and retain talent.
• Economic downturns or industry-specific challenges could impact the company's financial performance and stock price.
• Cybersecurity threats pose a risk to the company's operations and data security.
• The company's reliance on government contracts exposes it to risks associated with changes in government spending and priorities.

Future Outlook

The company expects the requested increase in shares under the Amended Plan to be sufficient for at least an additional three years.

Management Comments

• Glen R. Ives, President and Chief Executive Officer, expresses appreciation for stockholders' continued interest in the business.
• The Board believes that diversity is important to ensure that board members and senior management provide the necessary range of perspectives, experience, and expertise required to achieve effective stewardship and management.

Industry Context

Castellum, Inc. operates in the government contracting sector, where attracting and retaining qualified personnel is crucial. Equity-based compensation plans are common in this industry to align employee interests with those of the company and its stockholders.

Comparison to Industry Standards

• Castellum's executive compensation structure, including base salary, bonus, and equity incentives, aligns with industry standards for government contracting companies.
• Companies like Booz Allen Hamilton, Leidos, and CACI International also utilize stock option plans and other equity-based awards to incentivize their employees.
• The size of the proposed share increase under the stock incentive plan and the number of shares reserved for the employee stock purchase plan should be evaluated in comparison to similar companies in the industry to assess its competitiveness and potential dilution impact.

Corporate Governance

Legal Proceedings

• In October 2016, Nutroganics, Inc., a company in the natural foods industry, closed and filed for bankruptcy in the State of Delaware. Jay O. Wright, one of our executive officers and a director, was a director of Nutroganics, Inc. within two years of its bankruptcy.
• From May 2013 to May 2016, C. Thomas McMillen, a director of the Company since October 12, 2022, served as an independent director of RCS Capital Corporation ('RCS'). RCS filed a petition to reorganize under Chapter 11 of the Bankruptcy Code in January 2016 under a prepackaged plan with the consent of the majority of the creditors.
• On or about December 29, 2014, a securities class action lawsuit was filed in the U.S. District Court, Southern District of New York against RCS Corporation and certain of its affiliates, officers, and directors, including C. Thomas McMillen, alleging false and misleading statements pertaining to the company's financial position and future business prospects. The case is Weston v. RCS Capital Corporation, No. 14-cv-10136 (S.D.N.Y.). The case was settled in September 2017 without recourse to the independent directors of RCS Corporation, including Mr. McMillen.

Related Party Transactions

• On August 12, 2021, the Company entered into a note payable with Emil Kaunitz in the principal amount of $400,000, that has a maturity date of December 31, 2024 (the 'Kaunitz Note'). Emil Kaunitz is an employee of the Company and a former director of the Company.
• On February 15, 2024, the Company entered into an agreement with the former shareholders of SSI concerning the amount and timing of the contingent earnout included in total consideration related to the acquisition of SSI Acquisition in 2021. The former shareholders were both employed by the Company during 2024.

Stakeholder Impact

• Approval of the proposals could positively impact employees through the Employee Stock Purchase Plan and the potential for increased equity ownership.
• Stockholders may benefit from the company's ability to attract and retain talent, potentially leading to improved financial performance.
• The proposals do not appear to have a significant direct impact on customers, suppliers, or creditors.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will hold its Annual Meeting of Stockholders on May 28, 2025.
• The Board will implement the approved proposals following the Annual Meeting.

Key Dates

Keywords

proxy statement, annual meeting, directors, stock incentive plan, employee stock purchase plan, corporate governance, executive compensation, RSM US LLP, stockholders, Castellum